Resultado de búsqueda
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).
4 de feb. de 2021 · Kenneth Frazier, uno de los pocos directores ejecutivos negros que lideran las principales empresas estadounidenses, dimitirá como director ejecutivo del laboratorio Merck a finales de junio, y será reemplazado por el director financiero Robert Davis.
4 de feb. de 2021 · Merck CEO Kenneth Frazier, who is currently one of the few Black CEOs of a Fortune 500 company, is retiring in June, ending a nearly 30-year run with the company.
12 de jun. de 2023 · Listen to former Merck CEO Ken Frazier share his insights on how he led the company through challenges and opportunities, how he ensured that science stayed at the core of Merck's mission, and how he sees business's role in society. He also discusses his humble roots, his vision for Merck, and his views on R&D investments.
4 de feb. de 2021 · El consejero delegado de Merck (MSD, fuera de Estados Unidos y Canadá), Kenneth Frazier, dejará su cargo en junio de este año, luego de una década al frente de la farmacéutica y tras ...
4 de feb. de 2021 · Merck & Co's chief executive Kenneth Frazier is retiring at the end of June, the drugs company said. The firm said he would be replaced by current chief financial officer Robert Davis, who...
4 de feb. de 2021 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.
